Evidence map›Paper›PMID 37764423›Full record

ArticleMolecules (Basel, Switzerland)2023

Anti-Colorectal Cancer Activity of Solasonin from

Xintian Lan, Meng Lu, Xiaoxue Fang, Yiming Cao, Mingyang Sun, Mengyao Shan, Wenyi Gao, Yuchen Wang, Wenbo Yu, Haoming Luo

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xintian LanCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Meng LuCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Xiaoxue FangCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Yiming CaoCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Mingyang SunCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Mengyao ShanCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Wenyi GaoCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Yuchen WangCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Wenbo YuCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Haoming LuoCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Changchun University of Chinese Medicine · CN

Funding

Jilin Province Science and Technology Development Plan Item 20220204001YY, 20230401074YYJilin Provincial Development and Reform Commission 2021C035-5National Natural Science Foundation of China 81973468
6 · The paper itself

Abstract

(1) Background:

Indexed as

NeoplasmsSolanumSolanum nigrumAcetylationDown-RegulationHumansTumor Suppressor Protein p53Tumor Suppressor Protein p53colorectal cancerHDACP53Solanum nigrum L.Solasonin

Identifiers

PMID37764423
PMCPMC10534604
OpenAlexW4386838317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.